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Trichomonas vaginalis infection in men is an important cause of nongonococcal urethritis. Effective detection
of the parasite in men using culture requires examination of multiple specimens. We compared culture and
PCR–enzyme-linked immunosorbent assay in urethral swabs, urine, and semen for T. vaginalis detection in
male sexual partners of women with trichomoniasis identified by wet mount and culture. Trichomonads were
detected by at least one positive test in 205/280 men (73.2%) who submitted at least one specimen for culture
and PCR. Whereas InPouch TV culture detected only 46/205 cases (22.5%), PCR detected 201/205 (98.0%).
Urethral swab cultures from men with urethritis were more likely to be positive with shorter incubation than
specimens from men without urethritis. T. vaginalis was detected more often in men with wet-mount-positive
partners. Even with a sensitive PCR assay, reliable detection of T. vaginalis in male partners required multiple
specimens. The majority of male sexual partners in this study were infected, emphasizing the importance of
partner evaluation and treatment.
Infection with the protozoan parasite Trichomonas vaginalis
is the most common nonviral sexually transmitted infection
(STI), with prevalence estimates frequently surpassing those
for gonorrhea and chlamydia (36). Infection of the female
genital tract can result in vaginitis, cervicitis, and urethritis, and
trichomoniasis has been associated with adverse pregnancy
outcomes (4, 23, 26). Though it was once virtually ignored, T.
vaginalis infection in men is now recognized as an important
cause of nongonococcal urethritis (9, 27, 29) and is associated
with prostatitis (17, 25, 31) and male factor infertility (6, 21). In
addition, trichomoniasis is a risk factor for sexual transmission
of human immunodeficiency virus (HIV) (1, 3, 5, 19). T. vagi-
nalis disrupts the urogenital epithelia and enhances HIV rep-
lication in vitro (7). Increased vaginal and endocervical inflam-
mation in women and urethral inflammation in men with
trichomoniasis likely contribute to enhanced HIV transmis-
sion. Because trichomoniasis is so widespread, substantial pro-
portions of HIV infections might be attributable to T. vaginalis
infection in populations where both are prevalent (2, 32).
Few studies have examined concordant trichomoniasis in
sexual partners. In studies conducted in the early 1990s using
culture for T. vaginalis detection, infection was identified in 22
to 48% of male partners of women with trichomoniasis (14,
18). Since that time, more-sensitive nucleic acid amplification
assays have been developed for detection of the parasite (8, 10,
11, 13, 20, 22, 30). T. vaginalis detection in men is also im-
proved when multiple urogenital specimens are tested (12, 15,
16). The current study was designed to examine the concor-
dance of T. vaginalis infection in the male sexual partners of
women with trichomoniasis attending 3 sexually transmitted
diseases (STD) clinics in the United States. In this report, we
focus on the performance of culture and PCR from urethral
swabs, urine, and semen and culture from vaginal swabs for T.
vaginalis detection in women and their male partners.
MATERIALS AND METHODS
Study design and sample. Women with trichomoniasis and their male sexual
partners were enrolled in the public health department STD clinics located in
Durham and Raleigh, North Carolina, and in Birmingham, Alabama, in a clinical
study designed to examine concordance of T. vaginalis infection among sexual
partners. The study design is described in detail elsewhere (30a). Briefly, women
with trichomoniasis were identified on the basis of a vaginal swab positive by wet
mount or culture and were asked to identify their most frequent and most recent
sexual partner. The “most frequent” sexual partner was defined as the partner
with whom the woman had the greatest number of sexual encounters in the
preceding 60 days; the “most recent” partner was defined as the partner with
whom the subject last had sex prior to enrollment. Male partners aged 18 years
and older who presented to one of the STD clinics following standard referral or
conditional partner notification efforts were eligible for the study. Human ex-
perimentation guidelines of the U.S. Department of Health and Human Services
were followed in the conduct of this research. All enrolled subjects provided
written informed consent. The study was approved by the Institutional Review
Boards of the University of North Carolina at Chapel Hill and the University of
Alabama at Birmingham.
Clinical data and specimen collection. Study subjects received standard care
and treatment in the clinics and then responded to a questionnaire including
questions on demographics, STD signs and symptoms, STD history, and sexual
behaviors. Study specimens were obtained after routine clinic specimens; for the
men, this included a urethral swab for T. vaginalis culture and first-catch urine for
gonorrhea and chlamydia testing (Amplicor CT/NG PCR; Roche Diagnostics,
Indianapolis, IN), T. vaginalis culture, and PCR. To minimize discomfort for
study subjects, only a single urethral swab was collected. This swab was used for
culture but not PCR, since the former is an FDA-cleared test for detection of T.
vaginalis. Men were also asked to provide a semen specimen for T. vaginalis
culture and PCR. After specimen collection, all partners were given metronida-
zole (2 g orally in a single dose).
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All specimens were initially processed and culture pouches were inoculated at
the local health departments. Urine and semen specimens were transported to
research laboratories at University of North Carolina at Chapel Hill or Univer-
sity of Alabama at Birmingham for further processing and PCR testing as
described below.
T. vaginalis culture. Vaginal swabs from women and urethral swabs from men
were immediately used to inoculate the InPouch TV culture system (Biomed, White
City, OR). For urine sediment cultures, 10 ml of first-catch urine was centrifuged for
10 min at 1,500 rpm at room temperature. The supernatant was aspirated, 0.25 ml
of Diamond’s modified medium (Remel, Lenexa, KS) was added to the pellet, and
0.05 ml of resuspended sediment was used to inoculate the culture. The remain-
der of the resuspended urine sediment was stored at 4°C for up to 4 days before
processing for PCR. Semen was allowed to liquefy and was centrifuged for 10
min at 1,500 rpm at room temperature. The sediment from 0.5 to 1 ml of semen
was inoculated into an InPouch TV system, and the remaining sample was
centrifuged, resuspended in 0.1 ml of Diamond’s medium, and stored at 4°C for
up to 4 days before preparation for PCR. When the semen volume was 1 ml,
culture but not PCR was performed. All cultures were incubated in a humidified
atmosphere with 5% CO2 at 37°C and examined for at least 1 min per sample by
a trained microscopist daily for 5 days or until a positive result was obtained. A
positive culture was defined as visualization of parasites with morphology and
motility characteristic of T. vaginalis. No motile parasites were observed at any
reading in negative cultures.
T. vaginalis PCR-ELISA. For amplification of T. vaginalis DNA, we used the
previously described TV PCR–enzyme-linked immunosorbent assay (ELISA)
(11) with a slight modification of the specimen processing procedure. Urine or
semen sediment that had been resuspended in Diamond’s medium (0.5 ml) was
added to an equal volume of CT/NG urine wash solution from the Amplicor
CT/NG urine specimen prep kit (Roche Applied Science, Indianapolis, IN) and
further processed according to the manufacturer’s instructions. Specimens with
less than 0.5 ml were adjusted to 0.5 ml with sterile phosphate-buffered saline.
Fifty microliters of prepared sample was used as a template in the PCR as
previously described (11). Briefly, primers TVK3 and TVK7 (digoxigenin la-
beled) (13) were used to amplify T. vaginalis DNA. Positive and negative controls
were purified T. vaginalis DNA and sterile water, respectively. PCR products
were detected using the PCR DIG ELISA detection kit (Roche Diagnostic
Systems) with the biotinylated TVK probe and ELISA controls as described
previously (10). Standard measures were taken to minimize contamination. Sep-
arate workspaces were maintained for specimen processing, PCR, and post-PCR
work, and sterile, disposable laboratory supplies were used.
PCR primers TVK3 and TVK7 were previously tested against human DNA, a
variety of sexually transmitted pathogens, and other Trichomonas species and
were shown to amplify only T. vaginalis DNA (13). Additional analytical speci-
ficity was provided by the requirement for hybridization of the internal TVK
probe; any DNA spuriously amplified by the primers would not produce a
positive PCR-ELISA result. In first-catch urine (30 ml) from men, the assay
has a sensitivity of 92.7% and an adjusted specificity (corrected to account for the
imperfect sensitivity of T. vaginalis culture) of 95.2% compared to culture of
urethral swabs or urine sediment (11).
Data analysis. Laboratory data were double entered by two different members
of the study staff into a database created on EpiInfo 6.02 (CDC, Atlanta, GA).
Data were analyzed, without identifiers, using SAS version 8 (SAS institute, Cary,
NC), STATA version 7 (Stata Corp., College Station, TX), and SigmaStat ver-
sion 3.11 (Systat Software, Inc., Point Richmond, CA). For analyses of specimens
from the male partners, results from all men were included, whether they were
identified as the most frequent or the most recent partner of a woman in the
study. For women with 2 partners enrolled, results from only the most frequent
partner were included in analyses of associations involving characteristics of the
women.
RESULTS
Study population and specimens. A total of 540 women with
trichomoniasis were enrolled in the study from November 2001
through July 2003; 287 male partners of 261 women were
contacted and agreed to participate. Table 1 summarizes the
demographic and clinical characteristics of the participants.
While the majority of women (74%) in the study complained of
symptoms including vaginal discharge, vaginal itching, dysuria,
or lower abdominal pain, most of the men (75%) were asymp-
tomatic.
All 287 men provided first-catch urine for T. vaginalis cul-
ture; 10 urine specimens could not be processed for PCR
because of transport or laboratory problems, and 6 men de-
clined to provide a urethral swab for T. vaginalis culture (Fig.
1). Eighty-six men provided semen for T. vaginalis culture; 65
of these specimens contained a sufficient volume for PCR.
T. vaginalis detection by culture. InPouch TV cultures were
inoculated with vaginal swabs from women or with urethral
swabs, urine sediment, or semen sediment from men and vag-
inal swabs from women, and cultures were examined daily for
up to 5 days as described in Materials and Methods. We com-
pared the time to positive culture for 67 positive specimens
from men and 79 positive vaginal swabs from women with
negative wet mount results. Seventeen percent of positive cul-
tures did not become positive until 4 or 5 days after inocula-
tion. Results were similar for specimens from men and women
(data not shown). The day on which male cultures became
positive was not influenced by whether or not cultures from the
female partner had a wet-mount-positive result. Urethral swab









20 54 (10.0) 15 (5.2)
20–24 143 (26.5) 70 (24.4)
25–29 94 (17.4) 56 (19.5)
30–39 145 (26.9) 71 (24.7)
40 104 (19.3) 75 (26.1)
Race/ethnicity
Black, non-Hispanic 503 (93.2) 278 (96.9)
White, non-Hispanic 32 (5.9) 3 (1.1)
Black, Hispanic 1 (0.2) 1 (0.4)
White, Hispanic 1 (0.2) 0 (0.0)
Other 3 (0.6) 5 (1.7)
Clinical observations
Asymptomatica 140 (26.0) 215 (74.9)
Abnormal vaginal or penile
dischargeb
449 (83.2) 81 (28.2)
Elevated WBCs on cervical
or urethral Gram stainc
249/290 (85.9) 95 (33.1)
STId
T. vaginalis 540 (100.0) 206/287 (71.8)
N. gonorrhoeae 49 (9.9) 27/281 (9.6)
C. trachomatis 52 (11.9) 31/277 (11.2)
Syphilis 12 (2.4) 7/253 (2.8)
HIV 4 (1.5) 0/113 (0.0)
a Patients denied symptoms, including vaginal or penile discharge or itching,
dysuria, or lower abdominal pain.
b Observed by clinician during physical exam.
c Elevated WBC is defined as 5 or 4 WBC/hpf for cervical or urethral
Gram stain, respectively.
d T. vaginalis was diagnosed by vaginal swab wet mount or culture for women
and urethral, urine, or semen culture or urine or semen PCR for men. N.
gonorrhoeae and C. trachomatis were diagnosed by Amplicor CT/NG PCR from
first-void urine for men and according to routine clinic protocols for women.
Syphilis was diagnosed by positive rapid plasma reagin and confirmed by positive
Treponema pallidum hemagglutination assay. HIV was diagnosed by ELISA and
confirmed by Western blotting.
VOL. 44, 2006 T. VAGINALIS DETECTION IN HIGHLY EXPOSED MEN 3995
cultures from men with trichomoniasis and urethritis (urethral
discharge or 4 white blood cells [WBC]/high-power field
[hpf] on urethral gram stain) in the absence of gonorrhea or
chlamydial infection were slightly more likely to be positive on
the first day after inoculation than urethral swab cultures from
men with asymptomatic trichomoniasis (P  0.076, Fisher’s
exact test).
Significantly more trichomoniasis cases were identified by
PCR than by culture. Positive specimens and Trichomonas
detection test combinations are shown in Table 2. Among 287
male sexual partners of women with trichomoniasis who sub-
mitted at least one specimen for culture, T. vaginalis was de-
tected in 47 (16.4%) men. PCR identified 4 times more infec-
tions (P  0.001, chi-square test); T. vaginalis was detected in
201 (71.8%) of 280 partners who submitted at least one spec-
imen for PCR (Table 2). Overall, T. vaginalis was detected by
at least one positive test in 205/280 (73.2%) men who submit-
ted at least one specimen for culture and at least one specimen
for PCR. InPouch TV culture detected 47/205 cases (22.9%),
and PCR detected 201/205 cases (98.0%).
Testing multiple urogenital specimens from men increased
detection of T. vaginalis. Among 281 sets of urine specimens
and urethral swabs from male sexual partners of women with
trichomoniasis, T. vaginalis was detected by culture from at
least one specimen in 44 (15.7%) cases. Urethral swab cultures
were more sensitive than urine cultures with 79.5% of cases
diagnosed from swabs and 50.0% from urine (Fig. 2A) (P 
0.007, chi-square test). In a subset of 84 men who provided
urine specimens, urethral swabs, and semen for culture, T.
vaginalis was detected in at least 1 specimen in 12 (14.3%)
cases. Five urethral swabs, 8 urine specimens, and 9 semen
specimens were positive; all 3 specimens were positive in only
3 (25%) cases. In this small subset of samples, the sensitivities
of the 3 specimens were not significantly different. Compari-
sons of PCR detection in specimens from men in this study are
limited to urine and semen. From 62 men who provided both
urine and semen for PCR, T. vaginalis was detected in at least
one specimen in 49 (79.0%) cases. Urine was slightly, but not
significantly, more sensitive than semen (Fig. 2B) (P  0.144,
McNemar’s chi-square test).
Associations with T. vaginalis infection in male partners. In
this study, there were no significant associations between T.
vaginalis infection in men and urethritis (urethral discharge or
4 WBC/hpf on urethral gram stain) or chlamydial infection.
The prevalence of gonorrhea was higher in male partners with
trichomoniasis than in men in whom T. vaginalis was not de-
tected. This association was not statistically significant for men
in whom T. vaginalis was detected using urine (prevalence
ratio, 1.4; 95% confidence interval [CI], 0.6 to 3.4) or urethral
swab samples (prevalence ratio, 1.6; 95% CI, 0.6 to 3.8). How-
FIG. 1. Specimens obtained from male partners of women with
trichomoniasis. From 540 women in the study, 287 male partners were
enrolled. For analyses of specimens from the male partners, results
from all men were included, whether they were identified as a woman’s
most frequent partner (the partner with whom the woman had the
greatest number of sexual encounters in the preceding 60 days) or most
recent partner (the partner with whom the subject last had sex prior to
enrollment). For women with 2 partners enrolled, results from only the
most frequent partner were included in analyses of associations involv-
ing characteristics of the women.
TABLE 2. T. vaginalis detection in urogenital specimens from male
sexual partners of women with trichomoniasis




Culturea Urethral swab 35/281 12.5 8.8–16.9
Urine 23/287 8.0 5.2–11.8
Semen 9/86 10.5 4.9–18.9
Any 47/287 16.4 12.3–21.2
PCRb Urine 192/277 69.3 63.5–74.7
Semen 35/65 53.8 41.0–66.3
Any 201/280 71.8 66.1–77.0
a InPouch TV cultures read daily for up to 5 days after inoculation.
b PCR-ELISA with primers TVK3/7.
c Exact 95% CI.
FIG. 2. T. vaginalis detection in multiple urogenital specimens from
men. (A) Cases detected by use of urethral swab culture and urine
specimen culture. A total of 44 infections were identified from 281
men. (B) Cases detected by use of urine or semen PCR. A total of 49
infections were identified from 69 men.
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ever, among 63 men who provided semen for T. vaginalis de-
tection by PCR, the 2 infections were significantly associated
(P  0.027, Fisher’s exact test). In this subset, gonorrhea was
detected only in partners in whom T. vaginalis was detected in
the semen.
Trichomoniasis in men in the study, defined as T. vaginalis
detection in any specimen by culture or PCR, was influenced
by the female partner’s wet mount result (P  0.044, chi-
square test). Nearly 75% (169/226) of men with wet-mount-
positive partners were infected with T. vaginalis, compared to
60.4% (29/48) of men with wet-mount-negative partners (odds
ratio, 1.94; 95% CI, 1.01 to 3.73).
DISCUSSION
We detected T. vaginalis in 72% of the male sexual partners
of women with trichomoniasis, using culture and PCR from
urine, urethral swabs, and semen. Not surprisingly, substan-
tially more T. vaginalis infections in men were detected by PCR
than by culture. Others have reported similar results in recent
studies of T. vaginalis in men attending STD clinics (30, 35).
The study was designed to examine concordant infection in the
partners of women with trichomoniasis, and positive index
cases were defined using wet mount microscopy and culture
but not PCR. Because of the case ascertainment bias inherent
in using less-sensitive detection methods, the female study
population consisted of women with generally high organism
burdens of T. vaginalis, which is reflected in the large propor-
tion of symptomatic women. Consequently, the sexual partners
of women in the study comprised a population of men with
high exposure to T. vaginalis.
The T. vaginalis PCR assay used in this study was previously
validated with men’s urine (12); this is the first report of its use
with semen. There were too few culture-positive cases in men
identified in the current study to provide a valid reference
standard for conventional sensitivity and specificity calcula-
tions for the assay with semen, but we expect that the test
performs similarly with urine and semen. A limitation of the
assay is the lack of an internal amplification control. If the
specimen preparation procedure did not eliminate PCR inhib-
itors, false-negative results could have occurred. Thus, the
prevalence of T. vaginalis infection in the male partners of
infected women may be even higher than reported here.
Whether PCR or culture was used to detect T. vaginalis in
this population, testing multiple specimens from men substan-
tially increased the number of cases identified. If only one
specimen had been used for culture, 20 to 50% of cases would
have been missed. These results are consistent with previous
studies (12, 15, 16, 34) documenting recovery of T. vaginalis by
culture of multiple genitourinary specimens in men. Using
PCR to detect T. vaginalis, fewer missed cases would have
resulted from the use of a single specimen; nevertheless, PCR
detection from both urine and semen increased the number of
cases by 16% compared to urine alone. However, the study
design did not permit PCR testing from urethral swabs, and
this was the most sensitive sample type for culture. Thus, it is
possible that urethral swab PCR may have eliminated the ob-
served benefits of testing multiple specimens.
The incubation time required for positive InPouch TV cul-
tures was similar for specimens from men and vaginal swabs
from wet-mount-negative women. Approximately 17% of pos-
itive cultures required incubation for more than 3 days. We
observed cultures daily for up to 5 days after inoculation, in
accordance with the manufacturer’s instructions in an early
version of the product insert dated August 1999. The current
InPouch TV product insert instructs users to read cultures only
up to 3 days after inoculation. Following the current recom-
mendations, 1 of every 6 culture-positive specimens would
have been falsely classified as negative in this study.
Most of the male partners of women with trichomoniasis in
this study were asymptomatic, and overall, urethritis was not
significantly associated with trichomoniasis in this population.
Schwebke and Lawing also reported that urethritis was not
significantly associated with T. vaginalis infection in men at-
tending a U.S. STD clinic, using a combination of culture and
PCR (30). Using similar methods in a study conducted in an
STD clinic in Malawi, Price et al. showed that, while T. vagi-
nalis infection tended to be asymptomatic in HIV-negative
men, the clinical presentation of trichomoniasis was more se-
vere in men with HIV infection (28).
In the present study, cultures from men with urethritis were
slightly more likely to be positive on the first day after inocu-
lation than cultures from men without urethritis. Early positive
cultures are plausible indicators of infections with higher par-
asite loads, and urethral inflammation is more likely to accom-
pany such infections. Similarly, Wendel et al. observed an
association of urethritis in men with trichomoniasis detected by
culture but not by PCR (35). The superior sensitivity of nucleic
acid amplification tests compared to T. vaginalis culture cer-
tainly results in detection of more asymptomatic trichomonia-
sis in men by PCR, and such infections may have lower
organism burdens with less urethral inflammation. Whether
asymptomatic T. vaginalis infections pose a lower transmission
risk than symptomatic infections is not clear. Although we
cannot determine the direction of transmission within couples
in this study, the high rate of concordant infection among
sexual partners suggests that transmission does occur in the
context of asymptomatic infection in men. Using sensitive de-
tection methods with multiple specimens, self-limiting expo-
sures may also have been identified in some asymptomatic
men. Men with positive results from multiple specimens may
have had active infection, whereas those with a single positive
specimen represent detection of residual DNA.
Parasite loads are probably higher in women with trichomo-
niasis diagnosed by wet mount microscopy than in wet-mount-
negative, culture-positive women with T. vaginalis infections.
Consistent with this notion, we observed a higher prevalence of
trichomoniasis in the partners of wet-mount-positive women
than in the partners of women who were culture positive only.
This relationship was most evident when T. vaginalis infection
was defined as detection by any positive culture or PCR in the
male partners. However, in the related report by Seña et al.,
similar analyses were conducted using a more restrictive defi-
nition of infection in a subset of male partners, and the differ-
ences were not statistically significant (30a).
We examined the association of T. vaginalis infection and
coinfection with Neisseria gonorrhoeae and Chlamydia tracho-
matis in the male partners of women with trichomoniasis. Gon-
orrhea, but not chlamydial infection, was consistently more
frequent in men in whom T. vaginalis was detected, regardless
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of the specimen used for Trichomonas detection. High rates of
N. gonorrhoeae and T. vaginalis coinfection in men have been
previously reported (9, 24), probably reflecting the common
transmission routes and risk factors for the two infections. The
relationship between gonorrhea and trichomoniasis in male
partners in the current study was particularly strong among
men in whom T. vaginalis was detected in semen. The demo-
graphic characteristics of men who provided semen were not
different from those who did not (data not shown). T. vaginalis
in semen could represent more chronic or indolent infections
that are not spontaneously cleared. Prolonged effects on the
urogenital defense mechanisms of these men may make them
more susceptible to gonococcal infection.
In the current study, we identified a higher proportion of T.
vaginalis infection in the predominantly asymptomatic partners
of women with trichomoniasis than in previous studies that
relied on culture for parasite detection. However, even in this
population of highly exposed men, reliable detection of T.
vaginalis required the use of a sensitive nucleic acid amplifica-
tion test with multiple urogenital specimens. When T. vaginalis
is considered in the clinical evaluation of men, usually only
urine or a urethral swab is collected and inadequately sensitive
wet mount microscopy or culture is performed. In this and
previous studies (12), semen testing has been shown to sub-
stantially increase the number of T. vaginalis infections iden-
tified in men, and detection of the pathogen in semen is clin-
ically and epidemiologically important, since these infections
can be transmitted to partners through sexual intercourse.
However, collection of multiple urogenital specimens, espe-
cially semen, may not be practical outside clinical research
settings. Because clinical practices may not be “best practices”
with respect to T. vaginalis diagnosis in men on account of
financial or logistical constraints, it is important to emphasize
sexual partner notification and treatment among women with
trichomoniasis.
Despite increasing recognition of the importance of T. vagi-
nalis infection in men, parasite detection by nucleic acid am-
plification testing is not widely available in STD clinics. The
recent adaptation of a commercially available Chlamydia tra-
chomatis-Neisseria gonorrhoeae PCR assay for T. vaginalis de-
tection (33) and the commercial availability of a transcription-
mediated amplification research test (A. Sitay, J. Bungo, K.
Dickey, W. Weisburg, T. Aguirre, D. Fuller, L. Jasper, and T.
Davis, Abstr. 103rd Gen. Meet. Am. Soc. Microbiol., abstr.
C-120, 2003; D. H. Martin, R. A. Lillis, M. Nasumi, B. Smith,
C. Cammarata, D. Diodene and K. Dickey, Abstr. 16th Int.
Soc. Sex. Transm. Dis. Res., abstr.WP-129, 2005; M. M. Hobbs,
K. D. Rich, E. B. Quinlivan, R. Zeitlin, J. L. Schmitz and M. B.
Miller, Abstr. 106th Gen. Meet. Am. Soc. Microbiol., abstr.
C-096, 2006) should increase the use of molecular diagnostics
for T. vaginalis detection.
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